{
    "code": "02024692",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02024692",
    "time": "2022-07-22 07:49:41",
    "許可證字號": "衛署藥輸字第024692號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "116\/09\/10",
    "發證日期": "96\/09\/10",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00202469202",
    "中文品名": "骨力強注射液5毫克\/100毫升",
    "英文品名": "Aclasta 5mg\/100ml Solution for infusion",
    "適應症": "治療骨佩吉特氏病 (Paget’s disease of bone)治療停經後婦女的骨質疏鬆症，以降低發生髖關節、脊椎與非脊椎性骨折的機率，並增加骨密度。男性骨質疏鬆症之治療，以增加骨密度。Aclasta適用於治療及預防男性與女性因類固醇引起之骨質疏鬆症；這些病患為剛開始使用或持續使用每日劑量相當於7.5 mg prednisolone或更高劑量的全身性類固醇，且預期將持續使用類固醇至少12個月者。Aclasta預防停經後婦女的骨質疏鬆症。",
    "劑型": "270注射劑",
    "包裝": "100毫升注射塑膠瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "ZOLEDRONIC ACID",
    "限制項目": "02輸　入",
    "申請商名稱": "0901301200  美時化學製藥股份有限公司",
    "申請商地址": "台北市大安區信義路三段149號15樓",
    "主製造廠": [
        {
            "製造廠名稱": "FIT9117000  Corden Pharma S.p.A.",
            "製造廠廠址": "viale dell’Industria 3 Caponago 20867 Italy",
            "製造廠公司地址": "",
            "製造廠國別": "ITALY",
            "製程": "成品製造、一級包裝、二級包裝"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "6400001600",
            "成分名稱": "ZOLEDRONIC ACID",
            "含量描述": "(monohydrate 0.0533mg)",
            "含量": "0.0500000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Aclasta 1-104-09-16(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024692&Seq=002&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Aclasta_Round_3_ARTDB016769P2_clear-109-03-13(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024692&Seq=007&Type=9"
        },
        {
            "title": "020246920001-106-02-14.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024692&Seq=006&Type=9"
        },
        {
            "title": "ArtworkProof_CompID_19828_Round_2_ARTDB018555C-110-02-26(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024692&Seq=008&Type=8"
        },
        {
            "title": "Aclasta_Round_3_ARTDB016767C2_clear-109-03-13(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024692&Seq=007&Type=8"
        },
        {
            "title": "Aclasta 2-104-09-16(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024692&Seq=006&Type=8"
        }
    ]
}